Bristol-Myers Squibb(US:BMY) Jing Ji Guan Cha Wang·2025-12-12 03:09Core Insights - Bristol-Myers Squibb (BMS) is shifting its strategic focus in China from merely expanding market presence to co-creating an innovative ecosystem, emphasizing mutual empowerment and innovation as key objectives [1][2] Group 1: Strategic Focus - BMS's "China 2030 Strategy" was introduced in 2020, aiming to maintain steady performance, integrate and lead innovation ecosystems, and enhance talent development [2] - The three strategic focuses—performance, innovation, and talent—are interrelated, forming a closed loop that ensures China remains a core market globally [3] Group 2: Performance as a Foundation - Performance encompasses not only commercial success but also the synchronization of Phase III clinical trials and new drug registrations, aiming to enhance patient accessibility and impact from diagnosis to treatment [4] - Since the implementation of the "China 2030 Strategy," BMS has accelerated the introduction of innovative drugs, focusing on areas with unmet medical needs, including several global firsts in drug categories [4] - BMS has successfully integrated five innovative products into the national medical insurance directory within a year of their market launch, demonstrating a new speed in market access [4] Group 3: Innovation as an Engine - BMS aims to transition from being an innovator's importer to a leader in China's innovation ecosystem, emphasizing the importance of mutual empowerment with local partners [6] - The company seeks to identify Chinese innovations that can benefit global patients, focusing on strategic alignment with core disease areas and long-term value creation [6] Group 4: Talent as a Bridge - BMS is building a talent pool that understands both the Chinese market and global dynamics, essential for executing its "China 2030 Strategy" [7][8] - The company emphasizes the importance of diverse experiences in its talent acquisition and promotes cross-regional and cross-functional opportunities for internal development [8][9] Group 5: Long-term Vision - BMS's commitment to the Chinese market remains steadfast, evolving from a focus on market potential to recognizing the value of China's innovative ecosystem [9] - The company believes that understanding the vibrancy and resilience of the Chinese market will enhance its development prospects, aiming for dual innovation and empowerment as pathways to success [9]